Akt activation by estrogen in estrogen receptor-negative breast cancer cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11731414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Estrogen-Induced Activation of the Mitogen-Activated Protein Kinase Cascade in the Cerebral Cortex of Estrogen Receptor-α Knock-Out Mice

  2000cited by this paper
• Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase.

  2000cited by this paper
• Phosphatidylinositol 3‐kinase mediates neuroprotection by estrogen in cultured cortical neurons

  2000cited by this paper
• Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.

  2000cited by this paper
• Bombesin and Platelet-derived Growth Factor Induce Association of Endogenous Focal Adhesion Kinase with Src in Intact Swiss 3T3 Cells*

  1999influential reference
• Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells.

  1999cited by this paper
• Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells

  1999cited by this paper
• Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.

  1997influential reference
• Interleukin 3-dependent survival by the Akt protein kinase.

  1997cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells.

  1995cited by this paper
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.

  1995cited by this paper
• Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.

  1990cited by this paper

• Antioxidant Effects and Potential Molecular Mechanism of Action of Diplocyclos palmatus (L.) C. Jeffrey Fruits Based on Systematic Network Pharmacology with Experimental Validation

  2024cites this paper
• Prolactin Inhibition Promotes Follicle Recruitment by Increasing PIKfyve Expression in Ewes During the Estrus Stage

  2024cites this paper
• Estrogen receptor signaling and targets: Bones, breasts and brain (Review).

  2024cites this paper
• Oestrogen receptor-independent actions of oestrogen in cancer

  2023cites this paper
• Justification of the choice of hormone therapy for ovarian cancer

  2023cites this paper
• Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cells

  2022cites this paper
• Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells

  2020cites this paper
• Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.

  2019cites this paper
• 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy.

  2019cites this paper
• Sweroside promotes osteoblastic differentiation and mineralization via interaction of membrane estrogen receptor-α and GPR30 mediated p38 signalling pathway on MC3T3-E1 cells.

  2019cites this paper
• Regulation of breast cancer biomarkers by intrinsic and extrinsic factors

  2018cites this paper
• Expression of Oestrogen Receptor, Progesterone Receptor and Akt in Canine Circumanal Gland Tumours.

  2018cites this paper
• Synergism between BRCA1 Mutation and Impaired Estrogen Signaling in Oxidative Stress Modulation Makes Estrogen Responsive Tissues (Breast) More Susceptible to Develop Cancer

  2018cites this paper
• New piperidine derivative DTPEP acts as dual‐acting anti‐breast cancer agent by targeting ERα and downregulating PI3K/Akt‐PKCα leading to caspase‐dependent apoptosis

  2018cites this paper
• Investigating the effects of soy phytoestrogens on Nephrin and Akt podocyte survival signaling pathway

  2017cites this paper
• Network biology identifies novel apoptosis-related proteins and synergistic drug combinations in breast cancer

  2016cites this paper
• Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer

  2016cites this paper
• Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer

  2016cites this paper
• Impact of low concentrations of phthalates on the effects of 17β-estradiol in MCF-7 breast cancer cells.

  2016cites this paper
• Triple-negative breast cancer: investigating potential molecular therapeutic target

  2015cites this paper
• Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells.

  2015cites this paper
• Breast Cancer Genes PSMC3IP and EPSTI1 Play a Role in Apoptosis Regulation

  2015cites this paper
• Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication.

  2015cites this paper
• Role of ER-α36 in breast cancer by typical xenoestrogens

  2015cites this paper
• Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer.

  2015cites this paper
• Topical KGF treatment as a therapeutic strategy for vaginal atrophy in a model of ovariectomized mice

  2014cites this paper
• Mechanistic insight of drug resistance with special focus on iron in estrogen receptor positive breast cancer.

  2014cites this paper
• Lower concentrations of phthalates induce proliferation in human breast cancer cells

  2014cites this paper
• Use of mTOR inhibitors in the treatment of malignancies

  2014influential citation
• Fucoidan Extract Enhances the Anti-Cancer Activity of Chemotherapeutic Agents in MDA-MB-231 and MCF-7 Breast Cancer Cells

  2013cites this paper
• Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone

  2013cites this paper
• Estrogen protects SGC7901 cells from endoplasmic reticulum stress-induced apoptosis by the Akt pathway

  2013cites this paper
• Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney.

  2013cites this paper
• Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy

  2012cites this paper
• DAX-1 at the connection between Androgen Receptor and Aromatase: a novel mechanism in the inhibition of estrogen-dependent cancer cell proliferation

  2012cites this paper
• Estrogen and Progesterone enhance Neisseria gonorrhoeae Transmigration across a Polarized Monolayer via a Mechanism that Hijacks EGFR

  2012cites this paper
• Insulin growth factor receptor‐1 expression and loss of PTEN protein predict early recurrence in triple‐negative breast cancer

  2012cites this paper
• Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation

  2012cites this paper
• Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.

  2012cites this paper
• Molecular prognostic markers in soft tissue sarcomas

  2012cites this paper
• The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas

  2011cites this paper
• TLR4 AND PI3K/AKT PATHWAY ACTIVATION: NEW APPROACH FOR CANCER DETECTION

  2011cites this paper
• Estrogen inhibits the effects of obesity and alcohol on mammary tumors and fatty liver.

  2011cites this paper
• ER-Alpha36 Mediates Non-Genomic Estrogen and Anti-Estrogen Signaling in Breast Cancer Cells

  2011cites this paper
• In Vitro Enhancement of Radiosensitivity by the Combination of Celecoxib and Ad-mda7 in Human Breast Cancer Cells

  2010cites this paper
• Immunohistochemical Detection of Phospho-Akt, Phospho-BAD, HER2 and Oestrogen Receptors α and β in Malaysian Breast Cancer Patients

  2010cites this paper
• A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells

  2010cites this paper
• Inhibition of Estrogen-Induced Growth of Breast Cancer by Targeting Mitochondria Oxidants

  2010cites this paper
• Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.

  2010cites this paper
• Estrogen-induced apoptosis of breast epithelial cells is blocked by NO/cGMP and mediated by extranuclear estrogen receptors.

  2010cites this paper
• Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor α Transcriptional Activity in Breast Cancer Cells

  2009cites this paper
• Immuno-analysis of phospho-Akt in primary human breast cancers.

  2009cites this paper
• Mechanisms of transcriptional activation of estrogen responsive genes in breast cancer cells

  2009cites this paper
• ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

  2009cites this paper
• Akt2 inhibition enables the Forkhead transcription factor FoxO3a to a repressive role for ER αααα transcriptional activity in breast cancer cells

  2009cites this paper
• Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.

  2009cites this paper
• Estrogen and its receptors in cancer

  2008cites this paper
• Sensitizing estrogen receptor–negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor

  2008cites this paper
• Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells.

  2008cites this paper
• Analysis of the oestrogen response in an angiomyolipoma derived xenograft model.

  2008cites this paper
• Mifepristone attenuates human chorionic gonadotropin-induced extracellular signal-regulated kinase 1/2 phosphorylation, cyclooxygenase-2, and prostaglandin E2 production in human granulosa luteal cells.

  2008cites this paper
• Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers

  2008cites this paper
• Retraction: Sensitizing Estrogen Receptor–negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor

  2008cites this paper
• Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression.

  2007cites this paper
• Médicament préventif et curatif pour le cancer du sein er négatif ou her2 négatif et méthode de criblage

  2007cites this paper
• Growth-promoting effect of environmental endocrine disruptors on human neuroblastoma SK-N-SH cells.

  2007cites this paper
• Aromatase inhibitors in ovarian cancer: is there a role?

  2007cites this paper
• Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells.

  2006cites this paper
• Nitric oxide and hormones in breast cancer: allies or enemies?

  2006cites this paper
• The role of phosphoinositide 3-kinase/akt signaling pathway in tumor-associated angiogenesis, wound healing, and carcinogenesis.

  2006cites this paper
• Leptin Suppresses Human Chorionic Gonadotropin-Induced Cyclooxygenase-2 Expression and Prostaglandin Production in Cultured Human Granulose Luteal Cells

  2006cites this paper
• Regulation by phytoestrogens of migration, actin cytoskeleton, and signaling cascades relevant to cancer cell motility

  2006influential citation
• Molecular Connection Between Breast Cancer Proliferation and Metastasis Mediated by Akt Kinase

  2006cites this paper
• A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer

  2006cites this paper
• TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B.

  2006cites this paper
• The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

  2006cites this paper
• 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells.

  2006cites this paper
• Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer

  2006cites this paper
• Estrogenic Regulation of Host Immunity against an Estrogen Receptor–Negative Human Breast Cancer

  2006cites this paper
• Hormonal activation of genes through nongenomic pathways by estrogen and structurally diverse estrogenic compounds

  2006influential citation
• Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating Fas and Fas ligand expression.

  2006cites this paper
• 17β-Estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells

  2006cites this paper
• Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells

  2005cites this paper
• Molecular Cloning and Characterization of the Human AKT1 Promoter Uncovers Its Up-regulation by the Src/Stat3 Pathway*

  2005cites this paper
• Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

  2005cites this paper
• A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

  2005cites this paper
• Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms

  2005cites this paper
• Dual signaling mechanisms of estrogen: Phosphorylation of P53 at Ser15 in aging HMEC in the absence of estrogen receptor

  2005cites this paper
• Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.

  2005cites this paper
• Clinical Approaches to Discovering and Testing New Breast Cancer Prevention Drugs

  2005cites this paper
• NEONATAL EXPOSURE TO DI(N-BUTYL) PHTHALATE (DBP) ALTERS MALE REPRODUCTIVE-TRACT DEVELOPMENT

  2004cites this paper
• NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen.

  2004cites this paper
• Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.

  2004cites this paper
• Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer

  2004cites this paper
• Differential expression of VEGF-A mRNA by 17β-estradiol in breast tumor cells lacking classical ER-α may be mediated through a variant form of ER-α

  2004cites this paper
• Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells with Aberrant Akt Activity

  2004cites this paper
• Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol.

  2004cites this paper
• Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway

  2004cites this paper
• Involvement of Insulin/Phosphoinositide 3-Kinase/Akt Signal Pathway in 17β-Estradiol-mediated Neuroprotection*

  2004cites this paper
• Exposure to 4-tert-octylphenol, an environmentally persistent alkylphenol, enhances interleukin-4 production in T cells via NF-AT activation.

  2004cites this paper